Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 21 August 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Treatment response in NASH using advanced MRI

The latest issue of Alimentary Pharmacology & Therapeutics examiness the treatment response in non-alcoholic steatohepatitis using advanced magnetic resonance imaging.

News image

Magnetic resonance imaging-derived measures of liver fat and volume are emerging as accurate, non-invasive imaging biomarkers in non-alcoholic steatohepatitis (NASH). 

Little is known about these measures in relation to histology longitudinally.

Professor Loomba and colleagues from California, USA examined any relationship between MRI-derived proton-density fat-fraction, total liver volume, total liver fat index, vs. histology in a NASH trial.

The researchers performed a secondary analysis of a 24-week randomized, double-blind, placebo-controlled trial of 50 patients with biopsy-proven NASH randomized to oral ezetimibe 10 mg daily vs. placebo. 

Baseline and post-treatment anthropometrics, biochemical profiling, MRI and biopsies were obtained.

The research team found that baseline mean proton-density fat-fraction correlated strongly with total liver fat index, and had good correlation with total liver volume.

Mean total liver volume correlated strongly with total liver fat index. 

Total liver volume remained strongly correlated with total liver fat index
Alimentary Pharmacology & Therapeutics
After 24 weeks, the team noted that proton-density fat-fraction remained strongly correlated with total liver fat index, maintaining good correlation with total liver volume. 

The research found that total liver volume remained strongly correlated with total liver fat index. 

Patients with Grade 1 vs. 3 steatosis had lower proton-density fat-fraction, total liver volume, and total liver fat index. 

The research compared changes in MRI-proton-density fat-fraction vs. total liver volume, which indicated that 10% reduction in MRI-proton-density fat-fraction predicts 257 mL reduction in total liver volume.

Professor Loomba's team comments, "The MRI-proton-density fat-fraction and total liver volume strongly correlated with total liver fat index."

"Decreases in steatosis were associated with an improvement in hepatomegaly."

"Lower values of these measures reflect lower histologic steatosis grades."

"MRI-derived measures of liver fat and volume may be used as dynamic, and more responsive imaging biomarkers in a NASH trial, than histology."

Aliment Pharmacol Ther 2017: 45(6): 844–854
20 March 2017

Go to top of page Email this page Email this page to a colleague

 21 August 2017 
Improving medication adherence in IBD
 21 August 2017 
Treatments for chronic idiopathic constipation
 21 August 2017 
Ethnic disparities for chronic Hep C survival
 18 August 2017 
Proteomic analysis of IBD
 18 August 2017 
Pediatric intestinal failure
 18 August 2017 
Anti-TNF treatment and bowel resection in Crohn's
 17 August 2017 
Outcomes of ulcerative colitis patients undergoing pouch surgery
 17 August 2017 
Mortality in patients with asymptomatic pancreatic cystic neoplasms
 17 August 2017 
Survival after primary tumor resection in advanced colorectal cancer
 16 August 2017 
Assessment of seronegative villous atrophy
 16 August 2017 
Appendectomy and colectomy risk in ulcerative colitis
 16 August 2017 
Gluten sensitivity and celiac disease
 15 August 2017 
Infliximab and treatment failure during maintenance
 15 August 2017 
Genetic in idiopathic pancreatitis
 15 August 2017 
Genetic factors and tobacco in IBD
 14 August 2017 
Per oral endoscopic myotomy
 14 August 2017 
Early colonoscopy and symptomatic colorectal cancer
 14 August 2017 
Ethnic disparities and Hep C survival
 11 August 2017 
Ledipasvir and sofosbuvir in treatment-naïve Hep C
 11 August 2017 
EBV DNA to screen for nasopharyngeal cancer
 11 August 2017 
Direct acting antivirals and mixed cryoglobulinemia
 10 August 2017 
Routine preoperative laboratory tests for elective surgery
 10 August 2017 

Whole-genome sequencing in primary care

 10 August 2017 
Mortality in cirrhosis
 09 August 2017 
Anticoagulants in cirrhosis
 09 August 2017 
IBS with extraintestinal somatic and psychological symptoms
 09 August 2017 
Low birthweight and pediatric NAFLD
 08 August 2017 
Prior Barrett’s diagnosis and esophageal cancer survival
 08 August 2017 
Imaging index for fistulizing Crohn's
 08 August 2017 
Statin use after colon cancer
 07 August 2017 
Contraindications of biologic therapies in IBD
 07 August 2017 
Predicting clinical outcome in colorectal cancer
 07 August 2017 
Future burden of esophageal cancer
 04 August 2017 
Internet decision-making resources for ulcerative colitis surgery
 04 August 2017 
Distal findings and proximal colorectal neoplasia
 04 August 2017 
CT colonography vs flexible sigmoidoscopy
 03 August 2017 
Bloating and abdominal distension
 03 August 2017 
Predictors of colectomy in ulcerative colitis
 03 August 2017 
Treatment for sensitized transplant patients
 02 August 2017 
Preventing reactivation of Hep B
 02 August 2017 
Improving medication adherence in IBD
 02 August 2017 
Multiply recurrent C. difficile in the USA
 01 August 2017 
Coping with IBD
 01 August 2017 
Hepatocellular carcinoma in autoimmune hepatitis
 01 August 2017 
Anti-TNF treatment in Crohn's disease
 31 July 2017 
Global HCV incidence and mortality elimination targets
 31 July 2017 
Diagnosing GERD
 31 July 2017 
Diagnostic accuracy of severe liver fibrosis in patients with NAFLD
 28 July 2017 
Low FODMAP diet in IBS
 28 July 2017 
IBD patient–centered medical home
 28 July 2017 
Excluding NAFLD in the general population
 27 July 2017 
H. pylori infection and preeclampsia
 27 July 2017 
Colorectal cancer increases in developed and developing regions
 27 July 2017 
Anger in HIV-HCV co-infected patients
 26 July 2017 
Treating chronic pancreatitis
 26 July 2017 
Colorectal cancer screening
 26 July 2017 
Factors that influence H. pylori gastritis
 25 July 2017 
Influencing insulin resistance in patients with NAFLD
 25 July 2017 
IBD in immigrants from Cuba to the USA

 25 July 2017 
Split-dose bowel preparation for colonoscopy

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us